SALI/POC Advantage Paratus Diagnostics focuses on salivary tests and point-of-care device development, presenting a sales opportunity to partners seeking at-home or bedside diagnostics, rapid turnaround, and minimally invasive sampling.

Niche CLIA Capabilities As a high-complexity CLIA certified lab serving the US, there is a potential for collaborations in validated molecular testing, contract research, and outsourced diagnostic workflow services for healthcare providers and labs seeking capacity or specialty expertise.

Tech-Driven Platform Their integration of molecular biology, microfluidics, engineering, optics and systems processing signals a fit for vendors supplying lab automation, microfluidic components, analytical software, and cloud-based data management for secure result delivery.

Growth Signals With a modest revenue base and a total funding of eight million dollars, Paratus may be open to strategic partnerships, co-development, or early-stage investments to scale point-of-care platforms and accelerate market adoption.

Awarded Innovator Having received an innovation award for a novel point-of-care platform, the company can be approached for joint marketing, pilot programs, and pilot-site collaborations to validate and showcase real-world performance.